FilingIndex
AGSS10-KAMSS10-QPETVW10-KFMCQF11-KCTGO8-KBLTHS-1/AAURADEF 14AQLEP-UN8-KTOVXDEF 14AMLM8-KCURB424B5GL-PD8-KEXYNWS-1DLR-PJ8-KDFNSW8-KOTH8-K/APSKY8-KMODD10-KCTVA8-KSEQCS-1PPIH8-KOPRTDEFA14AAAVXF6-KMNRO11-KOPRTDEF 14AAIB8-KSWMR8-KRMCFDEF 14AALH8-KCVKD8-KAGSS10-KAMSS10-QPETVW10-KFMCQF11-KCTGO8-KBLTHS-1/AAURADEF 14AQLEP-UN8-KTOVXDEF 14AMLM8-KCURB424B5GL-PD8-KEXYNWS-1DLR-PJ8-KDFNSW8-KOTH8-K/APSKY8-KMODD10-KCTVA8-KSEQCS-1PPIH8-KOPRTDEFA14AAAVXF6-KMNRO11-KOPRTDEF 14AAIB8-KSWMR8-KRMCFDEF 14AALH8-KCVKD8-K
← VRDN · Viridian Therapeutics, Inc.DE
DEFA14AThe Ballot

Viridian Therapeutics, Inc.DE files DEFA14A

Filed Apr 17, 2026 · 2mo ago · Accession 0001193125-26-160349

Plain English

DEFA14A filed with the SEC.

Read the source below for the full document.

Read the original on SEC.gov ↗
Filing details
Company
Viridian Therapeutics, Inc.DE
Ticker
VRDN
CIK
1590750
Form type
DEFA14A
Filing date
Apr 17, 2026
Report date
—
Document
d904274ddefa14a.htm
Size
181 KB

More from VRDN

8-KReg FD Disclosure · Company UpdateJun 29, 20268-KShareholder VoteJun 3, 20268-KAgreement TerminatedMay 28, 20268-KMaterial AgreementMay 26, 2026SC 13D/AThe StakesMay 13, 20268-KMaterial Agreement · New Debt / ObligationMay 11, 2026